Estimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: Applying the screening method to data from intensive care surveillance systems

Epidemiology and Infection

Volumn 142, Issue 1, 2014, Pages 126-133

  Thomas, H L ^a,b   Andrews, N ^a   Green, H K ^a   Boddington, N L ^a   Zhao, H ^a   Reynolds, A ^c   McMenamin, J ^c   Pebody, R G ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

Author keywords

Immunization (vaccination); Influenza; Influenza vaccines

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; RISK FACTOR; SCREENING TEST; UNITED KINGDOM;

EID: 84890081848     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000824     Document Type: Article

References (24)

1. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season, February 2012 (http://www.who.int/influenza/vaccines/ virus/recommendations/2012-13- north/en/). Accessed 12 August 2012
2. Department of Health. Immunisation against Infectious Disease, 2006. Chapter 19. Influenza, updated 3 November 2011 (http://www.dh.gov.uk/prod- consum-dh/groups/ dh-digitalassets/documents/digitalasset/dh-131001.pdf). Accessed 12 July 2012
3. Kissling E, Valenciano M. I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Eurosurveillance 2012; 17: Pii=20146
4. Valenciano M, et al. Sudy designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28: 7381-7388
5. Pebody RG, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiology and Infection 2012; 13: 1-11
6. Hardelid P, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008- 2010: Results from a cohort study in general practice. Vaccine 2012; 30: 1371-1378
7. Hellenbrand W, et al. Prospective hospital-based casecontrol study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls. BMC Infectious Diseases 2012; 12: 127
8. Talbot HK, et al. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. Journal of Infectious Diseases 2011; 203: 500-508
9. Cheng AC, et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study. Vaccine 2011; 29: 7320-7325
10. Puig-Barberà J, et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study. Vaccine 2012; 30: 5714- 5720
11. Bolotin S, et al. A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period. PLoS One 2012; 7: E30279
12. Gates P, et al. Collection of routine national seasonal influenza vaccine coverage data from GP practices in England using a web-based collection system. Vaccine 2009; 27: 6669-6677
13. Farrington CP. Estimation of vaccine effectiveness using the screening method. International Journal of Epidemiology 1993; 22: 742-746
14. Health Protection Agency. Surveillance of influenza and other respiratory viruses in the UK: 2010-2011 report (http://www.hpa.org.uk/web/ HPAweb&HPAwebStandard/ HPAweb-C/1296687412376). Accessed 10 September 2012
15. Pebody RG, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: Evidence of waning intra-seasonal protection. Eurosurveillance 2013; 18: Pii=20389
16. Kissling E, Valenciano M. iMOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in target groups for vaccination: Results from the iMOVE multicentre case-control study, 2011-12. Eurosurveillance 2012; 17: Pii=20146
17. Hak E, et al. Confounding by indication in nonexperimental evaluation of vaccine effectiveness: The example of prevention of influenza complications. Journal of Epidemiology and Community Health 2002; 56: 951-955
18. Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006; 24: 6605-6611
19. Chen RT, Orenstein WA. Epidemiologic methods in immunization programmes. Epidemiologic Reviews 1996; 18: 99-117
20. Mary-Krause M, Mary J-Y, Valleron A-J. Conditions of validation and use of the screening method for vaccine efficacy evaluation. Revue d'Epidemiologie et de Sante Publique 1993; 41: 155-160
21. Joint Committee on Vaccination and Immunisation Statement the Annual Influenza Vaccination Programme. 16 November 2011 (http://www.dh.gov.uk/prod- consum- dh/groups/dh-digitalassets/@dh/@ab/documents/ digitalasset/dh-131106. pdf). Accessed 10 September 2012
22. Foster DA, et al. Influenza vaccine effectiveness in preventing hospitalisation for pneumonia in the elderly. American Journal of Epidemiology 1992; 136: 296-307
23. Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006; 24: 44-46
24. Bonmarin I, et al. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Eurosurveillance 2012; 17: Pii=20163